Clinical Trials Browser

Recruiting × Thyroid Carcinoma, Anaplastic × dabrafenib × Clear all

NCT03975231 2025-11-10

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Phase 1 Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT06362694 2024-04-12

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Phase 2 Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT06079333 2023-10-12

NEO-ATACT

Phase 2 Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic